Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7725247

Concept As at
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,136,000,000 JPY
2,101,000,000 JPY
Interest and dividends received
86,000,000 JPY
100,000,000 JPY
Interest paid
-217,000,000 JPY
-225,000,000 JPY
Income taxes paid
-584,000,000 JPY
-99,000,000 JPY
Net cash provided by (used in) operating activities
1,420,000,000 JPY
1,876,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-961,000,000 JPY
-1,838,000,000 JPY
Proceeds from sale of property, plant and equipment
743,000,000 JPY
1,374,000,000 JPY
Net cash provided by (used in) investing activities
-984,000,000 JPY
-786,000,000 JPY
Proceeds from sale of investment securities
73,000,000 JPY
2,000,000 JPY
Other, net
-166,000,000 JPY
-81,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-427,000,000 JPY
-282,000,000 JPY
Proceeds from long-term borrowings
4,600,000,000 JPY
3,500,000,000 JPY
Dividends paid
-706,000,000 JPY
-717,000,000 JPY
Redemption of bonds
-76,000,000 JPY
-76,000,000 JPY
Repayments of long-term borrowings
-3,456,000,000 JPY
-3,465,000,000 JPY
Net cash provided by (used in) financing activities
69,000,000 JPY
-1,145,000,000 JPY
Other, net
JPY
0 JPY
Net increase (decrease) in cash and cash equivalents
506,000,000 JPY
-55,000,000 JPY
Cash and cash equivalents
5,457,000,000 JPY
4,951,000,000 JPY
5,006,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.